Objective: To characterize the association between longitudinal changes in fasting serum glucose and changes in flourodeoxyglucose Positron Emission Tomography (FDG PET) measurements of regional cerebral metabolic rate for glucose (rCMRgl) in brain regions preferentially affected by Alzheimer's disease (AD). A secondary objective was to investigate whether higher fasting serum glucose levels are associated with lower rCMRgl in younger adults within these same AD relevant brain areas. Methods: For the primary study, baseline, interim, and 4.4 ± 1.0-year follow-up fasting serum glucose and PET CMRgl were analyzed in 80 cognitively unimpaired, non-diabetic, 61.5 ± 5 year-old persons with a first-degree family history of AD, including 38 carriers and 42 non-carriers of the apolipoprotein E (APOE) ε 4 allele. An automated brain-mapping algorithm was used to characterize associations between changes in fasting serum glucose levels and changes in rCMRgl. Longitudinal changes in fasting serum glucose levels and their correlation with changes in six pre-selected neuropsychological test measures of memory, attention and processing speed were also assessed with linear regression. The secondary study included a cross sectional sample of 31 cognitively unimpaired, non-diabetic participants, 31.2 ±5.4 years of age. General linear model-based voxel-wise analyses were performed to examine the correlation between fasting serum glucose and rCMRgl. Results: In the primary study of older adults, average fasting serum glucose levels increased over longitudinal measurement, and changes in these levels were inversely associated with longitudinal CMRgl changes in the vicinity of brain regions preferentially affected by AD (p<0.05, corrected for multiple comparisons). Fasting serum glucose was also inversely associated with performance on a measure of visuospatial memory (p<0.05, corrected for multiple comparisons). In the younger sample, fasting serum glucose levels were inversely associated with rCMRgl in left frontal pole and right primary visual cortex regions (p<.05, corrected for multiple comparisons).Conclusions: In older adults, fasting serum glucose increases across time and is inversely related to rCMRgl in AD relevant regions and to visual memory test scores. This relationship between serum glucose and regional brain metabolism may begin in metabolically sensitive areas at a younger age.

abstract: Cardiovascular disease has reached epidemic proportions resulting in its ranking as the number one cause of mortality in the Western world. A key player in the pathophysiology of vascular disease is oxidative stress due to free radical accumulation. This intervention study was conducted to evaluate any potential mediation of oxidative stress using a soil-derived organometallic compound (OMC) with suspected antioxidant properties. A 10-week study was conducted in male Sprague-Dawley rats (n = 42) fed either a high-fat diet (HFD) consisting of 60% kcal from fat or a standard Chow diet containing only 6% kcals from fat. Rats from each diet group were then subdivided into 3 subgroups (n = 6-10 each) that received 0.0 mg/mL, 0.6 mg/mL or 3.0 mg/mL OMC. Neither the diet nor OMC significantly changed protein expression of inducible nitric oxide synthase (iNOS) in isolated aortas. Plasma levels of the inflammatory marker, tumor necrosis factor alpha (TNFα) were below detection after the 10-week trial. Superoxide dismutase (SOD), a scavenger of the free radical, superoxide, was not significantly different following HFD although levels of SOD were significantly higher in Chow rats treated with 0.6 mg/mL OMC compared to HFD rats treated with the same dose (p < 0.05). Lipopolysaccharides (LPS) were significantly increased following 10 weeks of high fat intake (p < 0.05). This increase in endotoxicity was prevented by the high dose of OMC. HFD significantly increased fasting serum glucose levels at both 6 weeks (p < 0.001) and 10 weeks (p < 0.025) compared to Chow controls. The high dose of OMC significantly prevented the hyperglycemic effects of the HFD in rats at 10 weeks (p = 0.021). HFD-fed rats developed hyperinsulinemia after 10 weeks of feeding (p = 0.009), which was not prevented by OMC. The results of this study indicate that OMC may be an effective strategy to help manage diet-induced hyperglycemia and endotoxemia. However, further research is needed to determine the mechanism by which OMC helps prevent hyperglycemia as measures of inflammation (TNFα) and vascular damage (iNOS) were inconclusive. / Dissertation/Thesis / Masters Thesis Nutrition 2018

Introdução: A incidencia e prevalencia do Diabetes Mellitus aumentam a cada ano, alcancando proporcoes epidemicas. A infusao aquosa de erva mate apresenta consideraveis teores de acidos clorogenicos, que alem de atuarem como antioxidantes, podem diminuir a producao e absorcao de glicose, conforme indicado na literatura. Objetivos: Avaliar a influencia da ingestao de infusao de erva mate sobre parametros bioquimicos relacionados ao diabetes mellitus e o metabolismo de glicose. Metodologia: Ratos Wistar (n=41) foram divididos em: nao diabeticos controle (NDC, n=10); nao diabeticos erva mate (NDE, n=10); diabeticos controle (DC, n=11) e diabeticos erva mate (DE, n=10). O diabetes foi induzido por aloxana. Os animais receberam extrato de erva mate (1 g/kg) ou solucao fisiologica por gavagem durante 28 dias, com agua e racao comercial ad libitum. Seus tecidos foram submetidos as analises (glicemia, insulinemia, colesterol total, atividade da enzima glicose-6-fosfatase hepatica e expressao genica do cotransportador intestinal de Na+/glicose SGLT1, sendo este responsavel pela maior parte da absorcao de glicose no lumen). Os dados foram analisados por analise de variancia com dois fatores (ANOVA 2-way) com ou sem medidas repetidas, de acordo com a variavel. O nivel de significancia adotado foi 5%. Resultados: Nao houve diferenca significativa entre os grupos controle (NDC e DC) e os grupos que ingeriram erva mate (NDE e DE) para a glicemia, insulinemia, colesterol total e atividade da glicose-6-fosfatase hepatica. No entanto, a expressao genica 7 dos transportadores de glicose SGLT1 foi significantemente menor nos animais que receberam erva mate, tanto no duodeno (p=0,007) quanto no jejuno (p<0,001) Conclusão: A ingestao da erva mate nao modificou significativamente os parametros bioquimicos estudados dos animais sob intervencao relativamente ao controle. No entanto, foi observada diferenca significativa quanto a expressao do transportador de glicose SGLT1, sugerindo que compostos bioativos da erva mate sao capazes de reduzir a absorcao da glicose. / Introduction: The incidence and prevalence of Diabetes Mellitus are increasing, reaching epidemic proportions. Yerba mate infusions are rich in polyphenols, especially chlorogenic acids, that are known to have antioxidant properties. Evidences suggest that dietary polyphenols could also play a role in glucose metabolism and absorption. Objective: The aim of this study was to evaluate if yerba mate extract could have antidiabetic properties in alloxaninduced diabetic Wistar rats. Research design and methods: Wistar rats (n=41) were divided in four groups: non diabetic control (NDC, n=10); non diabetic yerba mate (NDM, n=10); diabetic control (DC, n=11) and diabetic yerba mate (DM, n=10). Diabetes was induced by alloxan (38 mg/kg bw). The mate group animals received yerba mate extract diluted in saline solution in a 1g extract/kg bw dose for 28 days, controls received saline solution only. The following biochemical parameters were measured: serum glucose, insulin and total cholesterol; hepatic glucose-6-fosfatase activity and gene expression of the intestinal Na+/glucose cotransporter SGLT1. Results: There were no significant differences in serum glucose, insulin, total cholesterol and hepatic glucose-6-phosphatase activity between the groups that ingested yerba mate extract (NDM and DM) and the controls (NDC and DC). However, the intestinal SGLT1 gene expression was significantly lower in animals that received yerba mate both in upper (p=0.007) and middle small intestine (p<0,001). Conclusion: These results indicate that bioactive 9 compounds present in yerba mate might be capable to decrease intestinal glucose absorption, by decreasing SGLT1 expression.

Introdução: A incidencia e prevalencia do Diabetes Mellitus aumentam a cada ano, alcancando proporcoes epidemicas. A infusao aquosa de erva mate apresenta consideraveis teores de acidos clorogenicos, que alem de atuarem como antioxidantes, podem diminuir a producao e absorcao de glicose, conforme indicado na literatura. Objetivos: Avaliar a influencia da ingestao de infusao de erva mate sobre parametros bioquimicos relacionados ao diabetes mellitus e o metabolismo de glicose. Metodologia: Ratos Wistar (n=41) foram divididos em: nao diabeticos controle (NDC, n=10); nao diabeticos erva mate (NDE, n=10); diabeticos controle (DC, n=11) e diabeticos erva mate (DE, n=10). O diabetes foi induzido por aloxana. Os animais receberam extrato de erva mate (1 g/kg) ou solucao fisiologica por gavagem durante 28 dias, com agua e racao comercial ad libitum. Seus tecidos foram submetidos as analises (glicemia, insulinemia, colesterol total, atividade da enzima glicose-6-fosfatase hepatica e expressao genica do cotransportador intestinal de Na+/glicose SGLT1, sendo este responsavel pela maior parte da absorcao de glicose no lumen). Os dados foram analisados por analise de variancia com dois fatores (ANOVA 2-way) com ou sem medidas repetidas, de acordo com a variavel. O nivel de significancia adotado foi 5%. Resultados: Nao houve diferenca significativa entre os grupos controle (NDC e DC) e os grupos que ingeriram erva mate (NDE e DE) para a glicemia, insulinemia, colesterol total e atividade da glicose-6-fosfatase hepatica. No entanto, a expressao genica 7 dos transportadores de glicose SGLT1 foi significantemente menor nos animais que receberam erva mate, tanto no duodeno (p=0,007) quanto no jejuno (p<0,001) Conclusão: A ingestao da erva mate nao modificou significativamente os parametros bioquimicos estudados dos animais sob intervencao relativamente ao controle. No entanto, foi observada diferenca significativa quanto a expressao do transportador de glicose SGLT1, sugerindo que compostos bioativos da erva mate sao capazes de reduzir a absorcao da glicose. / Introduction: The incidence and prevalence of Diabetes Mellitus are increasing, reaching epidemic proportions. Yerba mate infusions are rich in polyphenols, especially chlorogenic acids, that are known to have antioxidant properties. Evidences suggest that dietary polyphenols could also play a role in glucose metabolism and absorption. Objective: The aim of this study was to evaluate if yerba mate extract could have antidiabetic properties in alloxaninduced diabetic Wistar rats. Research design and methods: Wistar rats (n=41) were divided in four groups: non diabetic control (NDC, n=10); non diabetic yerba mate (NDM, n=10); diabetic control (DC, n=11) and diabetic yerba mate (DM, n=10). Diabetes was induced by alloxan (38 mg/kg bw). The mate group animals received yerba mate extract diluted in saline solution in a 1g extract/kg bw dose for 28 days, controls received saline solution only. The following biochemical parameters were measured: serum glucose, insulin and total cholesterol; hepatic glucose-6-fosfatase activity and gene expression of the intestinal Na+/glucose cotransporter SGLT1. Results: There were no significant differences in serum glucose, insulin, total cholesterol and hepatic glucose-6-phosphatase activity between the groups that ingested yerba mate extract (NDM and DM) and the controls (NDC and DC). However, the intestinal SGLT1 gene expression was significantly lower in animals that received yerba mate both in upper (p=0.007) and middle small intestine (p<0,001). Conclusion: These results indicate that bioactive 9 compounds present in yerba mate might be capable to decrease intestinal glucose absorption, by decreasing SGLT1 expression.